NCT07000682View on ClinicalTrials.gov

The Clinical Study on the Treatment of SSc With UTAA91 Injection.

EARLY_PHASE1RecruitingINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

May 30, 2025

Primary Completion Date

December 31, 2027

Study Completion Date

January 31, 2040

Conditions
Systemic Sclerosis (SSc)
Interventions
BIOLOGICAL

UTAA91 injection

CAR-modified gamma delta T cells

Trial Locations (1)

430000

RECRUITING

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan

All Listed Sponsors
lead

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

OTHER